Rebold, Nicholas
Alosaimy, Sara
Pearson, Jeffrey C.
Dionne, Brandon
Taqi, Ahmad
Lagnf, Abdalhamid
Lucas, Kristen
Biagi, Mark
Lombardo, Nicholas
Eudy, Joshua
Anderson, Daniel T.
Mahoney, Monica V.
Kufel, Wesley D.
D’Antonio, Joseph A.
Jones, Bruce M.
Frens, Jeremy J.
Baumeister, Tyler
Geriak, Matthew
Sakoulas, George
Farmakiotis, Dimitrios
Delaportas, Dino
Larew, Jeremy
Veve, Michael P.
Rybak, Michael J. http://orcid.org/0000-0002-1094-043X
Article History
Received: 13 November 2023
Accepted: 26 January 2024
First Online: 1 March 2024
Declarations
:
: Nicholas Rebold, Jeffery C. Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T. Anderson, Joseph A. D’Antonio, Jeremy J Frens, Tyler Baumeister, Matthew Geriak, Dino Delaportas, Jeremy Larew, and Michael P. Veve have no conflicts of interest to report. Sara Alosaimy is a current employee of Seres Therapeutics. Monica V. Mahoney has received funds for research from Merck; consulting funds from Cidara, Melinta, Merck, Pfizer, Qpex, and Spero; speaker honoraria from Paratek. Wesley D. Kufel has received research grants from Merck and Melinta; served on the advisory board for Theratechnologies, Inc.; Bruce M. Jones has received funds for consulting or participated in speaking bureaus for AbbVie, Melinta, Merck, Paratek, and La Jolla. George Sakoulas has consulted for Octapharma, AbbVie, and Paratek Pharmaceuticals and is on the speakers bureau for AbbVie and Paratek Pharmaceuticals. Dimitrios Farmakiotis has received research support from Astellas, Viracor and Merck, and consultation fee from Viracor. Michael J. Rybak has received funds for research and consulting or participated in speaking bureaus for AbbVie, Ferring, Melinta, Merck, Paratek Pharmaceuticals, Shionogi, Spero, La Jolla, and T2 Bioscience and was/is partially supported by National Institute of Allergy and Infectious Diseases R01 AI121400 and R21 AI163726. Michael J. Rybak is Editor in Chief of Infectious Diseases and Therapy. Michael J. Rybak was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
: This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. Approval was obtained from Wayne State University (#012019MP2E), Henry Ford Hospital (#14715), and all of the contributing medical centers with a waiver for informed consent due to the retrospective nature of the study design.